FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer
Simple Summary
- Supplementary File 1:
PDF-Document (PDF, 1287 KiB)
Sasaki, N.; Gomi, F.; Yoshimura, H.; Yamamoto, M.; Matsuda, Y.; Michishita, M.; Hatakeyama, H.; Kawano, Y.; Toyoda, M.; Korc, M.; Ishiwata, T. FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer. Cancers 2020, 12, 2976. https://doi.org/10.3390/cancers12102976
Sasaki N, Gomi F, Yoshimura H, Yamamoto M, Matsuda Y, Michishita M, Hatakeyama H, Kawano Y, Toyoda M, Korc M, Ishiwata T. FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer. Cancers. 2020; 12(10):2976. https://doi.org/10.3390/cancers12102976
Chicago/Turabian StyleSasaki, Norihiko; Gomi, Fujiya; Yoshimura, Hisashi; Yamamoto, Masami; Matsuda, Yoko; Michishita, Masaki; Hatakeyama, Hitoshi; Kawano, Yoichi; Toyoda, Masashi; Korc, Murray; Ishiwata, Toshiyuki. 2020. "FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer" Cancers 12, no. 10: 2976. https://doi.org/10.3390/cancers12102976